Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | NPC1 | O15118 | 3/20 | 0.64 |
| ▸ | RAB9A | P51151 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CASP7 | P55210 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50715 | 0.98 | KDM4E (0.66) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL29398625 | 0.98 | KDM4E (0.66) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| Hydrochloric Acid SCHEMBL3320794 | 0.96 | KDM4E (0.64) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL30090880 | 0.96 | KDM4E (0.64) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL29489796 | 0.96 | KDM4E (0.64) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL1686110 | 0.96 | KDM4E (0.64) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL30464099 | 0.96 | KDM4E (0.64) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL29400645 | 0.96 | KDM4E (0.64) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL31275980 | 0.96 | KDM4E (0.69) | KDM4ENPC1RAB9AMAPTL3MBTL1 | |
| SCHEMBL30497069 | 0.96 | KDM4E (0.64) | KDM4ENPC1RAB9AMAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2243177-A1 | PHOSPHORESCENT OLED HAVING DOUBLE HOLE-BLOCKING LAYERS | Global OLED Technology LLC (US) | 2010-10-27 | — | — | EP | claimed |
| EP-2158290-A1 | PHOSPHORESCENT OLED HAVING DOUBLE EXCITON-BLOCKING LAYERS | EASTMAN KODAK COMPANY (US) | 2010-03-03 | — | — | EP | claimed |
| WO-2009097108-A1 | PHOSPHORESCENT OLED HAVING DOUBLE HOLE-BLOCKING LAYERS | EASTMAN KODAK COMPANY (US) | 2009-08-06 | — | — | WO | claimed |
| WO-2008156554-A1 | PHOSPHORESCENT OLED HAVING DOUBLE EXCITON-BLOCKING LAYERS | EASTMAN KODAK COMPANY (US) | 2008-12-24 | — | — | WO | claimed |
| EP-3155669-B1 | METHOD FOR FABRICATING A LED PACKAGE WITH RED-EMITTING PHOSPHORS | CURRENT LIGHTING SOLUTIONS LLC (US) | 2024-03-27 | — | — | EP | disclosed |
| US-10968229-B2 | Seven-membered ring compounds | IDEMITSU KOSAN CO., LTD. (JP) | 2021-04-06 | — | — | US | disclosed |
| CN-109845404-B | Display device and method for manufacturing the same | 夏普株式会社 | 2020-11-20 | — | — | CN | disclosed |
| US-20190119291-A1 | SEVEN-MEMBERED RING COMPOUNDS | IDEMITSU KOSAN CO., LTD. (JP) | 2019-04-25 | — | — | US | disclosed |
| US-20160372687-A1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | BASF SE (DE) | 2016-12-22 | — | — | US | disclosed |
| US-9458182-B2 | Silyl- and heteroatom-substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and dibenzophospholes, and use thereof in organic electronics | BASF SE (DE) | 2016-10-04 | — | — | US | disclosed |
| US-20120012821-A1 | SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-01-19 | — | — | US | disclosed |
| EP-2385940-A1 | 2,4,6-TRI-(HETEROARYLPHENYL)-PYRIDINES AND ELECTRON-TRANSPORTING MATERIALS COMPRISING THEM | General Electric Company (US) | 2011-11-16 | — | — | EP | disclosed |
| US-8041982-B2 | Real time clock | TEXAS INSTRUMENTS INCORPORATED (US) | 2011-10-18 | — | — | US | disclosed |
| US-20100308308-A1 | USE OF SUBSTITUTED TRIS(DIPHENYLAMINO)TRIAZINE COMPOUNDS IN OLEDS | BASF SE (DE) | 2010-12-09 | — | — | US | disclosed |
| WO-2010080471-A1 | 2,4,6-TRI-(HETEROARYLPHENYL)-PYRIDINES AND ELECTRON-TRANSPORTING MATERIALS COMPRISING THEM | GENERAL ELECTRIC COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2007071450-A1 | ELECTRONIC DEVICE WITH A LAYER STRUCTURE OF ORGANIC LAYERS | NOVALED AG (DE) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190119291-A1 | SEVEN-MEMBERED RING COMPOUNDS | MCM7, XPO7, LUC7L2 | KDM4E 2621/4885NPC1 923/4885RAB9A 100/4885 |
| US-10968229-B2 | Seven-membered ring compounds | MCM7, XPO7, LUC7L2 | KDM4E 2621/4885NPC1 923/4885RAB9A 100/4885 |
| US-20120012821-A1 | SILYL- AND HETEROATOM-SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZOPHOSPHOLES, AND USE THEREOF IN ORGANIC ELECTRONICS | DDT, CDKL1, CDK2 | KDM4E 2857/4885NPC1 4516/4885RAB9A 3555/4885 |
| US-20160372687-A1 | MONOSUBSTITUTED DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES FOR USE IN ORGANIC LIGHT EMITTING DIODES | DDT, OCIAD1, OCIAD2 | KDM4E 2365/4885NPC1 4696/4885RAB9A 3618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.